C. H. Dash
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 5
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 12
- Drug-Induced Adverse Reactions 3
-
- Inhalation and Respiratory Drug Delivery 9
-
- Asthma and respiratory diseases 7
-
- Pneumonia and Respiratory Infections 4
-
- Orthopedic Infections and Treatments 4
-
- Pharmacological Effects and Assays 3
- Co-authors
- P. E. GowerBrenda MullingerH R GamsuP. DonnaiSean HughesSinead SavageArthur L. FrankC. S. Goodwin
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)European Journal of Clinical Pharmacology (3 papers)Postgraduate Medical Journal (2 papers)
- Partner nations
- United KingdomGermanyAustralia
In The Last Decade
C. H. Dash
27 papers receiving 380 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 65
- Pharmacology 183
- Pulmonary and Respiratory Medicine 156
- Pediatrics, Perinatology and Child Health 84
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by C. H. Dash
This map shows the geographic impact of C. H. Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. H. Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. H. Dash more than expected).
Fields of papers citing papers by C. H. Dash
This network shows the impact of papers produced by C. H. Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. H. Dash. The network helps show where C. H. Dash may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. H. Dash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 89 | |
| 2 | 1986 | 5 | |
| 3 | 1985 | 14 | |
| 4 | A new, modified form of inhaler ('Rotahaler') for patients with chronic obstructive lung disease. | 1985 | 8 |
| 5 | 1982 | 18 | |
| 6 | 1981 | 8 | |
| 7 | 1979 | 7 | |
| 8 | 1978 | 1 | |
| 9 | 1977 | 20 | |
| 10 | 1977 | 20 | |
| 11 | 1976 | 1 | |
| 12 | 1975 | 12 | |
| 13 | 1975 | 64 | |
| 14 | 1975 | 1 | |
| 15 | 1974 | 9 | |
| 16 | 1974 | 1 | |
| 17 | A comparison of betamethasone valerate, beclomethasone dipropionate and placebo by inhalation for the treatment of chronic asthma. | 1974 | 7 |
| 18 | 1973 | 12 | |
| 19 | 1972 | 8 | |
| 20 | 1969 | 45 |
About C. H. Dash
C. H. Dash is a scholar working on Molecular Medicine, Pharmacology, Transplantation, Pulmonary and Respiratory Medicine and Microbiology, having authored 28 papers that have together received 431 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Inhalation and Respiratory Drug Delivery (9 papers), Asthma and respiratory diseases (7 papers), Antibiotic Resistance in Bacteria (5 papers), Pneumonia and Respiratory Infections (4 papers), Orthopedic Infections and Treatments (4 papers), Drug-Induced Adverse Reactions (3 papers) and Pharmacological Effects and Assays (3 papers). The work is most often cited by research in Molecular Medicine (65 citations), Pharmacology (183 citations), Pulmonary and Respiratory Medicine (156 citations), Pediatrics, Perinatology and Child Health (84 citations) and Applied Microbiology and Biotechnology (8 citations). C. H. Dash has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include P. E. Gower, Brenda Mullinger, H R Gamsu, P. Donnai, Sean Hughes, Sinead Savage, Arthur L. Frank, C. S. Goodwin, A.David Goldberg and Richard Bax. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, European Journal of Clinical Pharmacology, Postgraduate Medical Journal, International Orthopaedics and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.